BRIEF-Sanofi initiates phase 2 clinical trial By: Reuters: Company News February 14, 2017 at 08:29 AM EST * Sanofi initiates phase 2 clinical trial to evaluate therapy for genetic form of parkinson's disease Source text for Eikon: Further company coverage: Read More >> Related Stocks: Banco Santander ADR